Immune response after vaccination against SARS-CoV-2
Conditions
Interventions
Group 1: We included the subjects with a full immunisation against COVID-19. Blood samples are collected 3 months, 6 months and 12 months after complete vaccination to measure antibody levels and neu
Sponsors
Uniklinik Tübingen
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Anyone over the age of 18 who is 14 days after the 2nd or 3rd vaccination or who has had a COVID-19 infection and only received one vaccination can participate. The age of admission is 18-75 years. The subjects should weigh at least 50 kg. The subject should not have any signs of infection, such as fever.
Exclusion criteria
Exclusion criteria: Subjects during pregnancy and breastfeeding are also excluded from the study. Subjects who have received a vaccine that is not approved in Germany are also excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study will be completed 12 months after full immunization or booster vaccination. The goal of the study is to gain insights to better understand the long-term immune response to COVID-19 vaccination. | — |
Countries
Germany
Contacts
Public ContactGünalp Uzun
Zentrum für klinische Transfusionsmedizin
Outcome results
None listed